Conference abstract · 26 Oct 2015
Conference abstractPublished 8 Jun 2018
Good manufacturing practices: The gap within (developing countries)
Makhealth Pharmaceuticals Ltd, Ghana
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Good Manufacturing Practice (GMP) is part of the quality management system which ensures that products are consistently produced and controlled to meet quality standards appropriate for their intended use as required by the marketing authorization, clinical trials authorization or product specification. Current Good Manufacturing practice (cGMP) is aimed at managing and minimizing the risks inherent in pharmaceutical manufacturing to ensure that the quality, safety and efficacy of products are reproducible. Such risks are essentially human errors which occur during the handling and processing of materials and machines. While most pharmaceutical industries from the industrialized world work tirelessly to comply with cGMP requirements to produce in compliant facilities, industries in the developing countries have not been able to meet most of these requirements. Factors such as lack of skilled personnel with technical know-how, weak regulatory systems, lack of appropriate equipment, machinery and technology and high cost of manufacturing drugs thus modern equipment and technology among others have been identified as some of the major factors within the sector bringing about the differences we see today in developing countries. In conclusion, GMP guidelines provide the requirements that a manufacturer must meet to ensure that their products are consistently high in quality, from batch to batch, for their intended use in order to always prevent harm from occurring to the end user
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Research article · 11 May 2015
On the production of CONAVIR® immune-booster by good manufacturing practice: Development of specifications for the herbal component.
Conference abstract · 25 Sep 2014
Historical developments of Good Manufacturing Practices
Commentary · 16 Jan 2025
Good Manufacturing Practices among Small and Medium Enterprises in Pharmacy
Commentary · 30 Dec 2024
The Role of Good Manufacturing Practices (GMP) in Pharmaceutical Quality Control
More from this journal
The newest in Journal of Developing Drugs.
Research article · 17 Jul 2026
Effects of a Food-Derived GLP-1 Formula on Endogenous GLP-1 Secretion and Appetite Responses: A Randomized Double-Blind Crossover Study
Commentary · 4 Feb 2026
Vaccine Development and Global Disease Prevention
Commentary · 4 Feb 2026
Transforming Drug Development Through Pharmaceutical Biotechnology
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Developing Drugs
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Bernice Brempong”

